Neuronetics Inc (STIM)
1.14
+0.04
(+4.11%)
USD |
NASDAQ |
Nov 05, 16:00
Neuronetics Total Liabilities (Quarterly): 77.43M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 77.43M |
| March 31, 2024 | 76.16M |
| December 31, 2023 | 81.64M |
| September 30, 2023 | 55.05M |
| June 30, 2023 | 54.92M |
| March 31, 2023 | 55.26M |
| December 31, 2022 | 59.82M |
| September 30, 2022 | 56.24M |
| June 30, 2022 | 54.53M |
| March 31, 2022 | 53.35M |
| December 31, 2021 | 56.05M |
| September 30, 2021 | 51.99M |
| June 30, 2021 | 50.93M |
| March 31, 2021 | 50.34M |
| Date | Value |
|---|---|
| December 31, 2020 | 53.16M |
| September 30, 2020 | 50.86M |
| June 30, 2020 | 50.55M |
| March 31, 2020 | 51.94M |
| December 31, 2019 | 52.32M |
| September 30, 2019 | 51.15M |
| June 30, 2019 | 49.61M |
| March 31, 2019 | 48.02M |
| December 31, 2018 | 45.98M |
| September 30, 2018 | 42.63M |
| June 30, 2018 | 233.62M |
| March 31, 2018 | 42.37M |
| December 31, 2017 | 231.59M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
50.34M
Minimum
Mar 2021
81.64M
Maximum
Dec 2023
57.50M
Average
54.53M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Quest Diagnostics Inc | 9.174B |
| Delcath Systems Inc | 29.72M |
| Star Equity Holdings Inc | 22.42M |
| CytoSorbents Corp | 36.69M |
| Progyny Inc | 242.44M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.81M |
| Shareholders Equity (Quarterly) | 19.39M |
| Debt to Equity Ratio | 3.082 |
| Current Ratio | 2.581 |
| Net Debt Paydown Yield | -8.52% |